Differentiating prescription omega-3-acid ethyl esters (P-OM3) from dietary-supplement omega-3 fatty acids

References

• Oh R. Practical applications of fish oil (omega-3 fatty acids) in primary care. J Am Board Fam Pract 2005;18:28–36
   PubMedGoogle Scholar
• Jump D. Fatty acid regulation of gene transcription. Crit Rev Clin Lab Sci 2004;41:41–78
   PubMed Web of Science ®Google Scholar
• Sampath H, Ntambi J. Polyunsaturated fatty acid regulation of gene expression. Nutr Rev 2004;62:333–9
   PubMed Web of Science ®Google Scholar
• Bezard J, Blond J, Bernard A, Clouet P. The metabolism and availability of essential fatty acids in animal and human tissues. Semin Nephrol 1994;34:539–68
   Google Scholar
• Kris-Etherton P, Harris W, Appel L, American Heart Association (AHA), AHA Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002;106: 2747–57
   Google Scholar
• Harris WS. Fish oil supplementation: evidence for health benefits. Cleve Clin J Med 2004;71:208–21
   PubMed Web of Science ®Google Scholar
• Abdel-Maksoud M, Hokanson J. The complex role of triglycerides in cardiovascular disease. Semin Vasc Med 2002;2:325–33
   Google Scholar
• Harris W. n-3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr 1997;65:1645S–54S
   Google Scholar
• Geleijnse J, Giltay E, Grobbee D, et al. Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J Hypertens 2002;20:1493–9
   PubMed Web of Science ®Google Scholar
• Knapp H. Dietary fatty acids in human thrombosis and hemostasis. Am J Clin Nutr 1997;65 (Suppl):1687S–98S
   Google Scholar
• Ander B, Weber A, Rampersad P, et al. Dietary flaxseed protects against ventricular fibrillation induced by ischemiareperfusion in normal and hypercholesterolemic rabbits. J Nutr 2004;134:3250–6
   PubMed Web of Science ®Google Scholar
• O’Keefe JJ, Abuissa H, Sastre A, et al. Effects of omega-3 fatty acids on resting heart rate, heart rate recovery after exercise, and heart rate variability in men with healed myocardial infarctions and depressed ejection fractions. Am J Cardiol 2006;97: 1127–30
   Google Scholar
• Leaf A, Kang J, Xiao Y, Billman G. Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils. Circulation 2003;107:2646–52
   PubMed Web of Science ®Google Scholar
• Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143–421
   PubMed Web of Science ®Google Scholar
• Nakamura T, Kugiyama K. Triglycerides and remnant particles as risk factors for coronary artery disease. Curr Atheroscler Rep 2006;8:107–10
   PubMedGoogle Scholar
• Lewis A, Lookinland S, Beckstrand R, Tiedeman M. Treatment of hypertriglyceridemia with omega-3 fatty acids: a systematic review. J Am Acad Nurse Pract 2004;16:384–95
   PubMedGoogle Scholar
• Harris W. n-3 fatty acids and lipoproteins: comparison of results from human and animal studies. Lipids 1996;31:243–52
   PubMed Web of Science ®Google Scholar
• Harris W, Bulchandani D. Why do omega-3 fatty acids lower serum triglycerides? Curr Opin Lipidol 2006;17:387–93
   PubMed Web of Science ®Google Scholar
• Bucher H, Hengstler P, Schindler C, Meier G. N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med 2002;112:298–304
   PubMed Web of Science ®Google Scholar
• Studer M, Briel M, Leimenstoll B, et al. Effect of different antilipidemic agents and diets on mortality: a systematic review. Arch Intern Med 2005;165:725–30
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration. Letter regarding dietary supplement health claim for omega-3 fatty acids and coronary heart disease (Docket No. 91N-0103). October 31, 2000 . Available at http://www.cfsan.fda.gov/~dms/ds-ltr11.html. Accessed February 12, 2007
   Google Scholar
• Brenna J. Efficiency of conversion of alpha-linolenic acid to long chain n-3 fatty acids in man. Curr Opin Clin Nutr Metab Care 2002;5:127–32
   PubMed Web of Science ®Google Scholar
• Arterburn L, Hall E, Oken H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr 2006;83(Suppl):1467S–76S
   Google Scholar
• Williams C, Burdge G. Long-chain n-3 PUFA: plant v. marine sources. Proc Nutr Soc 2006;65:42–50
   PubMed Web of Science ®Google Scholar
• Jump DB. The biochemistry of n-3 polyunsaturated fatty acids. J Biol Chem 2002;277:8755–8
   PubMed Web of Science ®Google Scholar
• Kris-Etherton P, Taylor D, Yu-Poth S, et al. Polyunsaturated fatty acids in the food chain in the United States. Am J Clin Nutr 2000;71:179S–88S
   Google Scholar
• Gebauer S, Psota T, Harris W, Kris-Etherton P. n-3 Fatty acid dietary recommendations and food sources to achieve essentiality and cardiovascular benefits. Am J Clin Nutr 2006;83(Suppl):1526S–35S
   Google Scholar
• Mahaffey K. Fish and shellfish as dietary sources of methylmercury and the ω-3 fatty acids, eicosahexaenoic acid and docosahexaenoic acid: risks and benefits. Environ Res 2004;95:414–28
   PubMed Web of Science ®Google Scholar
• Omacor® prescribing information. Liberty Corner, NJ: Reliant Pharmaceuticals, Inc., 2005
   Google Scholar
• Food and Drug Administration. United States Food and Drug Administration (Federal Register). Pharmaceutical cGMPS for the 21st Century – A Risk-Based Approach: Second Progress Report and Implementation Plan, 2003
   Google Scholar
• Vannice G. Omega-3 fatty acids from fish oil. Today’s Dietician 2005;7:32
   Google Scholar
• Food and Drug Administration. Compliance Program and Guidance Manual. Active Pharmaceutical Ingredient (API) Process Inspection. Revision Summary. FDA: Form FDA 2438g (electronic-09/2003). Available online at: http://www.fda.gov/cder/dmpq/7356–002f-CDER.pdf
   Google Scholar
• Borthwick L. The effects of an omega-3 ethyl ester concentrate on blood lipid concentrations in patients with hyperlipidaemia. Clin Drug Invest 1998;15:397–404
   PubMed Web of Science ®Google Scholar
• Calabresi L, Donati D, Pazzucconi F, et al. Omacor in familial combined hyperlipidemia: effects on lipids and low density lipoprotein subclasses. Atherosclerosis 2000;148:387–96
   PubMed Web of Science ®Google Scholar
• Chan D, Watts G, Mori T, et al. Randomized controlled trial of the effect of n-3 fatty acid supplementation on the metabolism of apolipoprotein B-100 and chylomicron remnants in men with visceral obesity. Am J Clin Nutr 2003;77:300–7
   PubMed Web of Science ®Google Scholar
• Durrington P, Bhatnagar D, Mackness M, et al. An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia. Heart 2001;85:544–8
   PubMed Web of Science ®Google Scholar
• Grundt H, Nilsen DW, Hetland O, et al. Improvement of serum lipids and blood pressure during intervention with n-3 fatty acids was not associated with changes in insulin levels in subjects with combined hyperlipidaemia. J Intern Med 1995;237:249–59
   PubMed Web of Science ®Google Scholar
• Pownall H, Brauchi D, Kilinc C, et al. Correlation of serum triglyceride and its reduction by ω-3 fatty acids with lipid transfer activity and the neutral lipid compositions of high-density and low-density lipoproteins. Atherosclerosis 1999;143:285–97
   PubMed Web of Science ®Google Scholar
• Mackness M, Bhatnagar D, Durrington P, et al. Effects of new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia. Eur J Clin Nutr 1994;48:859–65
   PubMed Web of Science ®Google Scholar
• Harris W, Ginsberg H, Arunakul N, et al. Safety and efficacy of Omacor in severe hypertriglyceridemia. J Cardiovasc Risk 1997;4:385–91
   PubMedGoogle Scholar
• Goodnight S, Harris W, Connor W, Illingworth D. Polyunsaturated fatty acids, hyperlipidemia, and thrombosis. Arteriosclerosis 1982;2:87–113
   PubMedGoogle Scholar
• Nair SS, Leitch JW, Falconer J, Garg ML. Prevention of cardiac arrhythmia by dietary (n-3) polyunsaturated fatty acids and their mechanism of action. J Nutr 1997;127:383–93
   PubMed Web of Science ®Google Scholar
• Vanschoonbeek K, Feijge M, Paquay M, et al. Variable hypocoagulant effect of fish oil intake in humans: modulation of fibrinogen level and thrombin generation (includes materials and methods addendum). Arterioscler Thromb Vasc Biol 2004;24:1734–40
   PubMed Web of Science ®Google Scholar
• Harris W. Expert opinion: omega-3 fatty acids and bleeding – cause for concern? Am J Cardiol 2007;99(6A):S44–6
   Google Scholar
• Bender N, Kraynak M, Chiquette E, et al. Effects of marine fish oils on the anticoagulation status of patients receiving chronic warfarin therapy. J Thromb Thrombolysis 1998;5:257–61
   PubMed Web of Science ®Google Scholar
• Dehmer G, Popma J, van den Berg E, et al. Reduction in the rate of early restenosis after coronary angioplasty by a diet supplemented with n-3 fatty acids. N Engl J Med 1988;319:733–40
   Google Scholar
• Eritsland J, Arnesen H, Gronseth K, et al. Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patency. Am J Cardiol 1996;77:31–6
   PubMed Web of Science ®Google Scholar
• Johansen O, Brekke M, Seljeflot I, et al. N-3 fatty acids do not prevent restenosis after coronary angioplasty: results from the CART study. Coronary Angioplasty Restenosis Trial. J Am Coll Cardiol 1999;33:1619–26
   PubMed Web of Science ®Google Scholar
• Fish Oil Supplements. Med Lett Drugs Ther 2006;48:59–60
   PubMed Web of Science ®Google Scholar
• Bryhn M, Hansteen H, Schanche T, Aakre S. The bioavailability and pharmacodynamics of different concentrations of omega-3 acid ethyl esters. Prostaglandins Leukot Essent Fatty Acids 2006;75:19–24
   PubMed Web of Science ®Google Scholar
• Sanders T, Sullivan D, Reeve J, Thompson G. Triglyceride-lowering effect of marine polyunsaturates in patients with hypertriglyceridemia. Arteriosclerosis 1985;5:459–65
   PubMedGoogle Scholar
• Zucker M, Bilyeu D, Helmkamp G, et al. The effects of dietary fish oil on platelet function and plasma lipids in hyperlipoproteinemic and normal subjects. Atherosclerosis 1988;73: 13–22
   PubMed Web of Science ®Google Scholar
• Chee K, Gong J, Rees D, et al. Fatty acid content of marine oil capsules. Lipids 1990;25:523–8
   PubMed Web of Science ®Google Scholar
• ConsumerLab.com. Product review: omega-3 fatty acids (EPA and DHA) from fish/marine oils. 2006
   Google Scholar
• Bays HE. Safety considerations with omega-3 fatty acid therapy. Am J Cardiol 2007;99(Suppl):35C–43C
   Google Scholar
• Food and Drug Administration Talk Paper. FDA finalizes rules for claims on dietary supplements. Available at http://vm.cfsan.fda.gov/~lrd/tpdsclm.html. Accessed 2 March 2006
   Google Scholar